IRIDEX (IRIX)

• Market cap: $15.8M
• 1 day: 0.00%
• 5 days: -5.04%
• 1 month: -14.54%
• 3 months: -3.08%
• 6 months: -45.34%
• Year to date: -48.63%
• 1 year: -56.07%
• 5 years: -55.23%
• 10 years: -89.09%
• Sector: Healthcare
• Industry: Medical Devices

About: IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Employees: 120

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

0% more funds holding in top 10

Funds holding in top 10: 1 [Q4 2024] → 1 (+0) [Q1 2025]

0.66% less ownership

Funds ownership: 19.4% [Q4 2024] → 18.74% (-0.66%) [Q1 2025]

11% less funds holding

Funds holding: 27 [Q4 2024] → 24 (-3) [Q1 2025]

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

41% less capital invested

Capital invested by funds: $5.43M [Q4 2024] → $3.19M (-$2.24M) [Q1 2025]

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $2K